Skip to main content
J

JOHNSON PHARMACARE LIMITED — Investor Relations & Filings

Ticker · 532154 ISIN · INE560F01022 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 308 across all filing types
Latest filing 2026-06-01 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 532154

About JOHNSON PHARMACARE LIMITED

Johnson Pharmacare Limited specializes in the wholesale and retail distribution of pharmaceutical products, chemicals, and surgical instruments. Incorporated in 1994, the company manages a diverse portfolio of medical goods, focusing on the procurement and supply of healthcare formulations to various market segments. Its core operations involve the trade of medicinal supplies, ensuring the availability of essential healthcare products through an established distribution network. The company serves as a link between manufacturers and healthcare providers, maintaining a focus on supply chain efficiency and the distribution of a broad range of therapeutic products and medical equipment.

Recent filings

Filing Released Lang Actions
meeting of board of director to considered and approved the following 1.audited financial results 2. Statement of deviation or variation 3. take note on resignation of Rajendra prasad (Non- ....
Interim / Quarterly Report Classification · 75% confidence The document is a formal submission under SEBI LODR Regulation 30/33 detailing the Board meeting outcome, including approval of the audited financial results (quarter & full year ended Mar 31, 2026) and the Independent Auditor’s Report. It contains substantive financial statements (statement of assets & liabilities, detailed IND-AS compliant P&L table) and is not merely a publication announcement. It is not a full annual report (10-K), nor just a press‐style highlights release (ER), but rather the actual quarterly/interim financial report with audited results. Hence it best fits the Interim/Quarterly Report category. FY 2026
2026-06-01 English
Annual secretarial compliance report for the F.Y 31ST MARCH 2026
Regulatory Filings Classification · 88% confidence The document is an Annual Secretarial Compliance Report issued by a Practicing Company Secretary under SEBI LODR Regulation 24A. It is an attestation/certification of regulatory compliance rather than a financial report or meeting material. Per the Certification Rule, officer certifications and compliance certificates are classified as Regulatory Filings (RNS).
2026-05-30 English
Submission of Extract of Newspaper Publication of Audited (Standalone) Financial Results for the quarter and year ended on 31st March 2026
Regulatory Filings Classification · 91% confidence The document begins as a formal letter from Johnson Pharmacare Limited to the BSE pursuant to SEBI LODR Regulation 47, stating that the company has published its audited standalone financial results in English and Hindi newspapers and is submitting the extract of those publications. It provides links to the newspaper ads and requests the exchange to take the information on record. This is not the full Annual or Interim Report itself but rather a compliance filing announcing the publication of financial results in newspapers. It does not constitute a comprehensive financial report or earnings press release, but is a regulatory compliance announcement. Therefore it falls under the general ‘Regulatory Filings’ category (RNS).
2026-05-28 English
DIsclosure of RPT
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under SEBI Listing Obligations (Regulation 23(9)) reporting that no related party transactions occurred during the year ended March 31, 2026. It is a mandatory regulatory announcement rather than a full report or financial statement, and does not fit specialized categories like dividends, board changes, or financial results. Therefore it is best classified as a general regulatory filing (RNS).
2026-05-27 English
Undertaking for Non- Applicability of Regul;ation 32 of SEBI (LODR) Regulation 2015 for the quarter and financial year ended 31st March 2026
Regulatory Filings Classification · 15% confidence The document is a formal compliance letter to the stock exchange certifying the non-applicability of Regulation 32 of SEBI (LODR) for the period ended March 31, 2026. It contains an officer’s undertaking rather than substantive financial data or report content. Therefore, it is a regulatory compliance filing and not a financial report, falling under Regulatory Filings (RNS).
2026-05-27 English
Submission of audited financial results for the quarter and financial year ended 3st March 2026
Interim / Quarterly Report Classification · 85% confidence The document is a detailed submission to the stock exchange of the company’s audited financial results under Regulation 33 of SEBI LODR, including full financial statements for the quarter (01.01.2026–31.03.2026) and the year to date (01.04.2025–31.03.2026), together with the auditor’s report. It is not merely an announcement of a report, nor a US‐style 10-K, proxy, M&A filing, or simple earnings highlight. It constitutes a comprehensive periodical financial report for a quarter (with YTD year-end numbers), containing substantive financial statements and audit opinion. Accordingly, it best matches the “Interim / Quarterly Report (IR)” category. FY 2026
2026-05-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.